Human model of duodenogastro-oesophageal reflux in the development of Barrett's metaplasia

British Journal of Surgery

Volumn 90, Issue 9, 2003, Pages 1120-1128

  Dresner, S M ^a   Griffin, S M ^a   Wayman, J ^a   Bennett, M K ^a   Hayes, N ^a   Raimes, S A ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACID; BILIRUBIN;

ADULT; AGED; ARTICLE; BARRETTS METAPLASIA; BIOPSY; CELL REGENERATION; CLINICAL ARTICLE; COLUMNAR EPITHELIUM; CONTROLLED STUDY; DEVICE; DISEASE CLASSIFICATION; DISEASE COURSE; DUODENOGASTRIC REFLUX; ENDOSCOPY; ESOPHAGITIS; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; FEMALE; GASTROESOPHAGEAL REFLUX; HISTOLOGY; HISTOPATHOLOGY; HUMAN; INCIDENCE; INTESTINE METAPLASIA; LOWER ESOPHAGUS SPHINCTER; MALE; METAPLASIA; MOBILIZATION; MODEL; MUCOSA; PATIENT MONITORING; PH; PLASTIC SURGERY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PYLOROPLASTY; SQUAMOUS EPITHELIUM;

ADULT; AGED; BARRETT ESOPHAGUS; BILIRUBIN; BIOPSY; ESOPHAGECTOMY; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; INTESTINAL MUCOSA; MALE; MANOMETRY; METAPLASIA; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 0141741287     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4169     Document Type: Article

References (35)

1. Blot WJ, Devesa SS, Fraumeni JF Jr. Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA 1993; 270: 1320.
2. Provenzale D, Kemp JA, Arora S, Wong JB. A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol 1994; 89: 670-680.
3. Bremner CG, Lynch VP, Ellis FH Jr. Barrett's esophagus: congenital or acquired? An experimental study of esophageal mucosal regeneration in the dog. Surgery 1970; 68: 209-216.
4. Harmon JW, Johnson LF, Maydonovitch CL. Effects of acid and bile salts on the rabbit esophageal mucosa. Dig Dis Sci 1981; 26: 65-72.
5. Kivilaakso E, Fromm D, Silen W. Effect of bile salts and related compounds on isolated esophageal mucosa. Surgery 1980; 87: 280-285.
6. Vaezi MF, Richter JE. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 1996; 111: 1192-1199.
7. Marshall RE, Anggiansah A, Owen WA, Owen WJ. The relationship between acid and bile reflux and symptoms in gastro-oesophageal reflux disease. Gut 1997; 40: 182-187.
8. Griffin SM. Surgery for cancer of the oesophagus. In Upper Gastrointestinal Surgery, Griffin SM, Raimes SA (eds). W.B. Saunders: London, 2001; 121-154.
9. Savary M, Miller G. The Esophagus. Handbook and Atlas of Endoscopy. Gassman: Switzerland, 1978; 135-139.
10. Bechi P, Pucciani F, Baldini F, Cosi F, Falciai R, Mazzanti R et al. Long-term ambulatory enterogastric reflux monitoring. Validation of a new fibreoptic technique. Dig Dis Sci 1993; 38: 1297-1306.
11. Johnson LF, DeMeester TR. Twenty four hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 1974; 62: 323-332.
12. Hamilton SR, Yardley JH. Regeneration of cardiac type mucosa and acquisition of Barrett mucosa after esophagogastrostomy. Gastroenterology 1977; 72: 669-675.
13. Lindahl H, Rintala R, Sariola H, Louhimo I. Cervical Barrett's esophagus: a common complication of gastric tube reconstruction. J Pediatr Surg 1990; 25: 446-448.
14. Gillen P, Keeling P, Byrne PJ, West AB, Hennessy TP. Experimental columnar metaplasia in the canine oesophagus. Br J Surg 1988; 75: 113-115.
15. Pera M, Cardesa A, Bombi JA, Ernst H, Pera C, Mohr U. Influence of esophago-jejunostomy on the induction of adenocarcinoma of the distal esophagus in Sprague-Dawley rats by subcutaneous injection of 2,6-dimethylnitrosomorpholine. Cancer Res 1989; 49: 6803-6808.
16. Nishimaki T, Watanabe K, Suzuki T, Hatakeyama K, Watanabe H. Early esophageal adenocarcinoma arising in a short segment of Barrett's mucosa after total gastrectomy. Am J Gastroenterol 1996; 91: 1856-1857.
17. Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK. The histologic spectrum of Barrett's esophagus. N Engl J Med 1976; 295: 476-480.
18. Hayward J. The lower end of the oesophagus. Thorax 1961; 16: 36-41.
19. Chandrasoma P. Pathophysiology of Barrett's esophagus. Semin Thorac Cardiovasc Surg 1997; 9: 270-278.
20. Oberg S, Peters JH, DeMeester TR, Chandrasoma P, Hagen JA, Ireland AP et al. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg 1997; 226: 522-530.
21. Oberg S, Peters JH, DeMeester TR, Lord RV, Johansson J, DeMeester SR et al. Determinants of intestinal metaplasia within the columnar-lined esophagus. Arch Surg 2000; 135: 651-655.
22. Cooper JE, Spitz L, Wilkins BM. Barrett's esophagus in children: a histologic and histochemical study of 11 cases. J Pediatr Surg 1987; 22: 191-196.
23. Hassall E, Weinstein WM. Partial regression of childhood Barrett's esophagus after fundoplication. Am J Gastroenterol 1992; 87: 1506-1512.
24. Qualman SJ, Murray RD, McClung HJ, Lucas J. Intestinal metaplasia is age related in Barrett's esophagus. Arch Pathol Lab Med 1990; 114: 1236-1240.
25. Cameron AJ, Lomboy CT. Barrett's esophagus: age, prevalence and extent of columnar epithelium. Gastroenterology 1992; 103: 1241-1245.
26. Csendes A, Maluenda F, Braghetto I, Csendes P, Henriquez A, Quesada MS. Location of the lower oesophageal sphincter and the squamous columnar mucosal junction in 109 healthy controls and 778 patients with different degrees of endoscopic oesophagitis. Gut 1993; 34: 21-27.
27. DeMeester TR, Peters JH, Bremner CG, Chandrasoma P. Biology of gastroesophageal reflux disease: pathophysiology relating to medical and surgical treatment. Annu Rev Med 1999; 50: 469-506.
28. Oberg S, DeMeester TR, Peters JH, Hagen JA, Nigro JJ, DeMeester SR et al. The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. J Thorac Cardiovasc Surg 1999; 117: 572-580.
29. Fitzgerald RC, Omary MB, Triadafilopoulos G. Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model. J Clin Invest 1996; 98: 2120-2128.
30. Kauer WK, Peters JH, DeMeester TR, Ireland AP, Bremner CG, Hagen JA. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg 1995; 222: 525-531.
31. Caldwell MT, Lawlor P, Byrne PJ, Walsh TN, Hennessy TP. Ambulatory oesophageal bile reflux monitoring in Barrett's oesophagus. Br J Surg 1995; 82: 657-660.
32. Marshall RE, Anggiansah A, Owen WA, Owen WJ. The temporal relationship between oesophageal bile reflux and pH in gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 1998; 10: 385-392.
33. Pfaffenbach B, Hullerum J, Orth KH, Langer M, Stabenow-Lohbauer U, Lux G. Bile and acid reflux in long and short segment Barrett's esophagus, and in reflux disease. Z Gastroenterol 2000; 38: 565-570.
34. Mendes de Almeida JC, Chaves P, Pereira AD, Altorki NK. Is Barrett's esophagus the precursor of most adenocarcinomas of the esophagus and cardia? A biochemical study. Ann Surg 1997; 226: 725-733.
35. Cameron AJ, Lomboy CT, Pera M, Carpenter HA. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995; 109: 1541-1546.